CounterX Therapeutics Revenue

Biotechnology Research • Seattle, Washington, United States • 1-10 Employees

CounterX Therapeutics revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at CounterX Therapeutics

Shawn Iadonato

Chief Executive Officer

Company overview

Headquarters	Seattle, Washington, United States
Website	counterxtherapeutics.com
NAICS	541714
Employees	1-10

CounterX Therapeutics Email Formats

CounterX Therapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@counterxtherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@counterxtherapeutics.com	100%

About CounterX Therapeutics

CounterX Therapeutics is at the forefront of the battle against the opioid epidemic, exploiting cutting-edge biotechnology to develop life-saving antibody drugs and vaccines. Our mission is to end the opioid epidemic and offer hope to individuals, families, and communities devastated by this crisis.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

CounterX Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

CounterX Therapeutics has never raised funding before.

Frequently asked questions

CounterX Therapeutics is located in Seattle, Washington, US.

CounterX Therapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

CounterX Therapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CounterX Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at CounterX Therapeutics

Shawn Iadonato

Chief Executive Officer

4.8

40,000 users